INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2023.
  • Invivo Therapeutics Holdings Corp. Operating Income (Loss) for the quarter ending September 30, 2023 was -$2.83M, a 1% decline year-over-year.
  • Invivo Therapeutics Holdings Corp. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$9.86M, a 11.3% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Operating Income (Loss) for 2022 was -$10.7M, a 7.58% decline from 2021.
  • Invivo Therapeutics Holdings Corp. annual Operating Income (Loss) for 2021 was -$9.9M, a 8.83% decline from 2020.
  • Invivo Therapeutics Holdings Corp. annual Operating Income (Loss) for 2020 was -$9.1M, a 20.9% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$9.86M -$2.83M -$28K -1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$9.83M -$2.09M +$645K +23.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$10.5M -$2.49M +$177K +6.64% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 -$10.7M -$2.46M +$458K +15.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 -$11.1M -$2.8M -$347K -14.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$10.8M -$2.73M -$420K -18.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$10.3M -$2.67M -$441K -19.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$9.9M -$2.91M -$722K -33% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$9.18M -$2.45M -$170K -7.45% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$9.01M -$2.31M -$115K -5.24% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$8.89M -$2.22M +$204K +8.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$9.1M -$2.19M +$548K +20% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 -$9.65M -$2.28M +$449K +16.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$10.1M -$2.2M +$1.05M +32.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$11.1M -$2.43M +$350K +12.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$11.5M -$2.74M +$271K +9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$11.8M -$2.73M -$619K -29.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$11.1M -$3.25M -$436K -15.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$10.7M -$2.78M +$2.05M +42.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$12.8M -$3.01M +$1.67M +35.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 -$14.4M -$2.11M +$4.2M +66.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$18.6M -$2.81M +$4.11M +59.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$22.8M -$4.83M +$1.84M +27.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$24.6M -$4.68M +$2.15M +31.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$26.7M -$6.32M -$438K -7.45% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$26.3M -$6.93M -$1.14M -19.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$25.2M -$6.67M -$1.1M -19.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 -$24.1M -$6.83M -$1.57M -29.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$22.5M -$5.88M -$9K -0.15% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-30
Q2 2016 -$22.5M -$5.79M -$26K -0.45% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$22.5M -$5.57M -$56K -1.02% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$22.4M -$5.26M -$1.41M -36.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 -$21M -$5.87M -$1.68M -40.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$19.3M -$5.76M -$1.02M -21.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$18.3M -$5.51M -$440K -8.68% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$17.8M -$3.84M +$1.83M +32.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$19.7M -$4.19M +$1.22M +22.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$20.9M -$4.74M +$333K +6.57% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$21.2M -$5.07M -$2.22M -77.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$19M -$5.68M -$953K -20.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-04
Q3 2013 -$18.1M -$5.41M -$2.57M -90.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$15.5M -$5.07M -$2.32M -84.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$13.2M -$2.85M -$390K -15.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$12.8M -$4.72M -$2.2M -87.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-11
Q3 2012 -$10.6M -$2.84M -$628K -28.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$9.95M -$2.76M -$228K -9.01% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 -$9.72M -$2.46M -$1.06M -75.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$8.66M -$2.52M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 -$2.21M -$1.46M -196% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$2.53M -$1.73M -218% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$1.4M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 -$749K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$794K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.